IMC Chicago’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.6M | Sell |
955,300
-60,600
| -6% | -$4.67M | 0.02% | 401 |
|
|
2025
Q4 | $80.6M | Sell |
1,015,900
-282,600
| -22% | -$22.3M | 0.03% | 349 |
|
|
2025
Q3 | $97.9M | Buy |
1,298,500
+71,800
| +6% | +$4.92M | 0.04% | 276 |
|
|
2025
Q2 | $84.6M | Sell |
1,226,700
-335,800
| -21% | -$22M | 0.04% | 271 |
|
|
2025
Q1 | $106M | Sell |
1,562,500
-403,900
| -21% | -$24.2M | 0.06% | 170 |
|
|
2024
Q4 | $88.3M | Buy |
1,966,400
+855,800
| +77% | +$48M | 0.04% | 225 |
|
|
2024
Q3 | $69.8M | Buy |
1,110,600
+26,700
| +2% | +$1.56M | 0.04% | 234 |
|
|
2024
Q2 | $64M | Buy |
1,083,900
+561,500
| +107% | +$35.1M | 0.04% | 240 |
|
|
2024
Q1 | $41.7M | Buy |
522,400
+17,100
| +3% | +$1.31M | 0.03% | 288 |
|
|
2023
Q4 | $39.9M | Sell |
505,300
-27,900
| -5% | -$1.99M | 0.03% | 303 |
|
|
2023
Q3 | $37.2M | Sell |
533,200
-96,600
| -15% | -$6.84M | 0.03% | 241 |
|
|
2023
Q2 | $43.5M | Buy |
629,800
+33,500
| +6% | +$2.38M | 0.04% | 212 |
|
|
2023
Q1 | $44.3M | Buy |
596,300
+286,300
| +92% | +$24M | 0.05% | 195 |
|
|
2022
Q4 | $28.9M | Buy |
310,000
+85,300
| +38% | +$8.23M | 0.05% | 244 |
|
|
2022
Q3 | $21.4M | Buy |
224,700
+22,600
| +11% | +$2.24M | 0.03% | 272 |
|
|
2022
Q2 | $18.7M | Sell |
202,100
-34,500
| -15% | -$3.37M | 0.03% | 303 |
|
|
2022
Q1 | $23.9M | Sell |
236,600
-44,700
| -16% | -$4.7M | 0.02% | 311 |
|
|
2021
Q4 | $29M | Sell |
281,300
-45,700
| -14% | -$4.22M | 0.02% | 298 |
|
|
2021
Q3 | $27.7M | Buy |
327,000
+28,900
| +10% | +$2.42M | 0.03% | 290 |
|
|
2021
Q2 | $24.9M | Buy |
298,100
+37,900
| +15% | +$3.1M | 0.03% | 289 |
|
|
2021
Q1 | $19.6M | Sell |
260,200
-107,700
| -29% | -$7.84M | 0.03% | 298 |
|
|
2020
Q4 | $25.1M | Buy |
367,900
+172,800
| +89% | +$11.2M | 0.03% | 232 |
|
|
2020
Q3 | $11.4M | Buy |
195,100
+33,600
| +21% | +$2.09M | 0.02% | 294 |
|
|
2020
Q2 | $10.5M | Sell |
161,500
-38,600
| -19% | -$2.43M | 0.02% | 258 |
|
|
2020
Q1 | $11.9M | Buy |
200,100
+53,100
| +36% | +$3.54M | 0.03% | 191 |
|
|
2019
Q4 | $10.9M | Sell |
147,000
-7,000
| -5% | -$492K | 0.03% | 203 |
|
|
2019
Q3 | $9.71M | Sell |
154,000
-12,000
| -7% | -$711K | 0.03% | 185 |
|
|
2019
Q2 | $9.04M | Buy |
166,000
+75,700
| +84% | +$4.08M | 0.03% | 186 |
|
|
2019
Q1 | $4.87M | Buy |
90,300
+53,100
| +143% | +$3.28M | 0.02% | 247 |
|
|
2018
Q4 | $2.44M | Buy |
+37,200
| New | +$2.78M | 0.01% | 310 |
|
Other funds holding CVS
VCM
VPM
IMC Chicago's CVS Position: Q1 2026 in Review
IMC Chicago reduced its CVS Health (CVS) stake by 35% in Q1 2026, selling an estimated $3.62M and leaving 86,636 shares worth $6.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1615.
IMC Chicago first reported a position in CVS in Q1 2020 and has held it in 6 quarters since. The position peaked at $10.6M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- IMC Chicago held 86,636 shares of CVS Health worth $6.22M as of Q1 2026.
- IMC Chicago sold 46,975 CVS Health shares in Q1 2026, an estimated $3.62M.
- CVS Health made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #1615 holding.
- IMC Chicago first reported a position in CVS Health in Q1 2020 and has held it in 6 quarters since.
- IMC Chicago's CVS Health position peaked at $10.6M in Q4 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.